v3.26.3
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Line Items]                    
Net sales $ 656,400 $ 653,000 $ 1,899,500 $ 1,890,000            
Cost of goods sold 327,800 309,600 915,700 895,300            
Deferred Revenue 61,200   61,200       $ 62,900      
Retained earnings 8,479,200   8,479,200       8,176,300      
Accumulated other comprehensive loss (315,300)   (315,300)       (189,100)      
Total stockholders' equity $ 7,603,000 6,736,800 $ 7,603,000 6,736,800 $ 7,173,900 $ 6,851,300 7,453,600 $ 7,128,700 $ 6,679,400 $ 6,569,300
Revenue Allocation Percent To Lease Elements 3.00%   3.00%              
Additional paid-in-capital $ 470,100   $ 470,100       476,000      
Selling, general and administrative expense 257,100 206,800 681,500 623,300            
Research and Development Expense 71,400 71,300 195,500 205,300            
Interest expense 12,300 12,300 36,700 36,900            
Other Nonoperating Income (Expense) 10,400 8,300 58,000 61,700            
Deferred Revenue, Current 47,100   47,100       $ 48,900      
Europe [Member]                    
Organization, Consolidation and Presentation of Financial Statements [Line Items]                    
Net sales 231,400 222,200 667,400 639,200            
Asia Pacific [Member]                    
Organization, Consolidation and Presentation of Financial Statements [Line Items]                    
Net sales 137,000 121,000 369,200 351,500            
UNITED STATES                    
Organization, Consolidation and Presentation of Financial Statements [Line Items]                    
Net sales 244,800 270,000 730,100 778,600            
Americas [Member]                    
Organization, Consolidation and Presentation of Financial Statements [Line Items]                    
Net sales $ 43,200 $ 39,800 $ 132,800 $ 120,700